Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIntuitive Investment Group Regulatory News (IIG)

Share Price Information for Intuitive Investment Group (IIG)

Share Price is delayed by 15 minutes
Get Live Data
300.00    10.00 (3.33%)
Bid:
290.00
Ask:
310.00
Spread: 20.00 (6.897%)
Market Cap: £741.85m
IIG Live PriceLast checked at - London Stock Exchange

Intraday Intuitive Investment Group Share Chart

Total Voting Rights

1 Feb 2024 14:23

RNS Number : 7542B
Intuitive Investments Group plc
01 February 2024
 

1 February 2024

 

Intuitive Investments Group plc

Total Voting Rights

 

Intuitive Investments Group plc (SFM2: IIG) ("IIG" or the "Company"), a closed-end investment company focussed on the life sciences sector, announces that in accordance with the Financial Conduct Authority's Disclosure and Transparency Rules, the Company has 2,012,430,046 ordinary shares of 1 penny each in issue, none of which are held in treasury. Therefore, the total number of voting rights in the Company is 2,012,430,046.

 

The above figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in the interest in, the share capital of the Company.

 

Intuitive Investments Group plc

www.iigplc.com

Sir Nigel Rudd, Independent Non-Executive Chairman

Robert Naylor, CEO

Via SP Angel Corporate Finance LLP

 

SP Angel Corporate Finance LLP 

+44 (0)20 3470 0470

Jeff Keating / David Hignell / Kasia Brzozowska

 

FTI Consulting

Jamie Ricketts / Valerija Cymbal / Jemima Gurney

IIG@fticonsulting.com

 

 

About Intuitive Investments Group plc

Intuitive Investments Group plc is an investment company seeking to provide investors withexposure to a portfolio concentrating on fast growing and/or high potential Life Sciences businessesoperating predominantly in the UK, continental Europe and the US, utilising the Board's experienceand in particular that of the Chairman of the Investment Committee, David Evans, to seek togenerate capital growth over the long term for shareholders.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TVREALAFEAALEFA
Date   Source Headline
20th Apr 202211:13 amRNSDispensation from Rule 9 of the Code
4th Apr 202211:13 amRNSTotal Voting Rights
8th Mar 20223:39 pmRNSHolding(s) in Company
2nd Mar 20227:00 amRNSSubscription
25th Feb 202212:11 pmRNSInvestment & Appointment of Non-Executive Chair
14th Feb 202212:59 pmRNSChange of Registered Office
14th Feb 20227:00 amRNSInvestment in Ocutec Limited
24th Jan 20228:45 amRNSDirector Dealing
30th Dec 202110:58 amRNSResult of AGM
20th Dec 20217:00 amRNSChange of Registered Office
6th Dec 20217:00 amRNSFinal Results and Notice of AGM
29th Nov 20217:00 amRNSChange of Adviser
5th Nov 202110:12 amRNSHolding(s) in Company
28th Oct 20211:38 pmRNSNotice of Results
15th Oct 20218:01 amRNSLight Science Technologies Holdings - Floatation
12th Oct 20219:48 amRNSLight Science Technologies - Intention To Float
20th Sep 20218:04 amRNSLight Science Technologies Holdings - update
15th Sep 20217:00 amRNSInvestment in Momentum Bioscience Limited
20th Aug 20213:40 pmRNSDirector Dealing
29th Jun 202110:56 amRNSInvestment in Midatech Pharma PLC
2nd Jun 20217:00 amRNSInterim report
28th May 20212:18 pmRNSInvestment in Trellus Health plc
4th May 20217:00 amRNSInvestment in The Electrospinning Company Limited
9th Apr 202111:01 amRNSIssue of Shares and Total Voting Rights
1st Apr 20217:00 amRNSInvestment in Axol Bioscience Ltd
31st Mar 20214:18 pmRNSInvestment in Altair
31st Mar 202112:00 pmRNSInvestment in CardiNor AS
17th Mar 20217:00 amRNSInvestment in Polarean Imaging plc
16th Mar 20217:00 amRNSInvestment in Micrima Limited
1st Mar 20217:00 amRNSInvestment in Shield Therapeutics plc
22nd Feb 20217:00 amRNSInvestment in Yourgene Health plc
12th Feb 202111:41 amRNSProposed Investment in Kromek Pharma plc
8th Feb 202111:08 amRNSHolding(s) in Company
3rd Feb 20217:00 amRNSProposed Investment in Evgen Pharma plc
29th Jan 20217:00 amRNSPortfolio company BioQ Pharma receives CE mark
25th Jan 20217:00 amRNSProposed Investment in Microsaic Systems plc
21st Jan 20214:41 pmRNSSecond Price Monitoring Extn
21st Jan 20214:35 pmRNSPrice Monitoring Extension
21st Jan 20217:00 amRNSInvestment in BioQ Pharma
11th Jan 20217:00 amRNSPre-IPO Investment in Light Science Technologies
14th Dec 20207:00 amRNSAIM Admission & First Day of Dealings
17th Jul 200610:58 amPRNDirector/PDMR Shareholding
30th Jun 200610:19 amPRNIssue of Equity
20th Jun 20063:08 pmPRNDirector/PDMR Shareholding
2nd Jun 200612:20 pmPRNCorrection : Holding(s) in Company
2nd Jun 200612:05 pmPRNHolding(s) in Company
16th May 200610:35 amPRNDirector/PDMR Shareholding
8th May 20062:30 pmPRNAdditional Listing
27th Apr 20061:07 pmPRNDirectorate Change
13th Apr 20069:46 amPRNDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.